Table 5 Test results from a clinical field study investigating the efficacy and safety of combination product chewable tablets administered orally once a month for 11 months for the prevention of heartworm disease in the USA
Treatment group | Study day | Adult HW antigen test | Microfilaria test | ||||||
|---|---|---|---|---|---|---|---|---|---|
Negative | Positive | Negative | Positive | ||||||
No. of dogs | % | No. of dogs | % | No. of dogs | % | No. of dogs | % | ||
Moxidectin/Sarolaner/Pyrantel combination product | 330 | 246 | 100 | 0 | 0 | 246 | 100 | 0 | 0 |
Heartgard® Plus | 330 | 117 | 98.3 | 2 | 1.7 | 118 | 99.2 | 1 | 0.8 |